MASCC recommendations on the management of constipation in patients with advanced cancer
The Palliative Care Study Group of the Multinational Association for Supportive Care in Cancer formed a subgroup to develop evidence-based recommendations on the management of constipation in patients with advanced cancer.
These recommendations were developed in accordance with the MASCC Guidelines Policy. A search strategy for Medline was developed, and the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials were explored for relevant reviews/trials respectively. The recommendations were categorised by the level of evidence and a “category of guideline” based on the level of evidence (i.e. “recommendation”, “suggestion”, or “no guideline possible”).
The group produced 15 recommendations, with varying levels of evidence and so varying categories of guideline. The recommendations relate to the assessment, the treatment, and the re-assessment of constipation.
These recommendations provide a framework for the management of constipation in advanced cancer, although every patient needs individualised management.
KeywordsConstipation Neoplasms Palliative care Practice guideline
Compliance with ethical standards
Conflict of interest
ADavies has received personal fees and research funding from Kyowa Kirin; CL has received personal fees from Kyowa Kirin; ADickman has received personal fees from Kyowa Kirin; DF has received personal fees from Novartis, Pfizer, and Roche.
- 4.Larkin PJ, Cherny NI, La Carpia D, Guglielmo M, Ostgathe C, Scotte F et al (2018) Daignosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol 29(Suppl 4):iv94–iv108Google Scholar
- 5.Anonymous (2010) Oxford concise medical dictionary, 8th edn. Oxford University Press, OxfordGoogle Scholar
- 8.Lee TH, Choi SC, Park MI, Park KS, Shin JE, Kim SE, Jung KW, Koo HS, Kim WJ, Cho YK, Kim YS, Lee JS, (2014) Constipation misperception is associated with gender, marital status, treatment utilization and constipation symptoms experienced. J Neurogastroenterol Motil 20:379–387Google Scholar
- 10.Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O’Brien T, Morlion B et al (2018) Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United European Gastroenterol JGoogle Scholar
- 12.Hadley G, Derry S, Moore RA, Wiffen PJ (2013) Transdermal fentnayl for cancer pain. Cochrane Database of Systematic Reviews Issue 10. Art. No.: CD010270Google Scholar
- 16.Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Gootjes JRG, Nabal M, Noguera A, Ripamonti C, Zucco F, Zuurmond WWA, On behalf of The European Consensus Group on Constipation in Palliative Care (2008) The management of constipation in palliative care: clinical practice recommendations. Palliat Med 22:796–807CrossRefGoogle Scholar
- 25.Multinational Association for Supportive Care in Cancer Guidelines Policy: https://www.mascc.org/assets/Toolbox/PoliciesForms/mascc_guideline_policy_2018.pdf Accessed 4th November 2018
- 26.National Cancer Institute Dictionary of Cancer https://www.cancer.gov/publications/dictionaries/cancer-terms Accessed 4th November 2018
- 27.Cochrane Database of Systematic Reviews: https://www.cochranelibrary.com/cdsr/about-cdsr Accessed 4th November 2018
- 28.Cochrane Central Register of Controlled Trials (CENTRAL): https://www.cochranelibrary.com/central/about-central Accessed 4th November 2018
- 29.National Institute for Health and Care Excellence (2015) Naloxegol for treating opioid-induced constipation. Technology Appraisal Guidance [TA345]. NICE, LondonGoogle Scholar
- 33.Starreveld JS, Pols MA, Van Wijk HJ, Bogaard JW, Poen H, Smout AJ (1990) The plain abdominal radiograph in the assessment of constipation. Z Gastroenterol 28:335–338Google Scholar
- 37.Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V, for the Expert Working Group of the European Association of Palliative Care Network (2001) Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19:2542–2554CrossRefGoogle Scholar
- 38.Candy B, Jones L, Larkin PJ, Vickerstaff V, Tookman A, Stone P (2015) Laxatives for the management of constipation in people receiving palliative care. Cochrane Database of Systematic Reviews Issue 5. Art. No.: CD003448Google Scholar
- 40.Lee-Robichaud H, Thomas K, Morgan J, Nelson RL (2010) Lactulose vesrus polyethylene glycol for chronic constipation. Cochrane Database of Systematic Reviews Issue 7. Art. No.: CD007570Google Scholar
- 43.British Medical Association and the Royal Pharmaceutical Society (2017) British National Formulary 74. Pharmaceutical Press, BasingstokeGoogle Scholar
- 45.Thomas J, Karyer S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE et al (2008) Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 358: 2332-2343. Send toGoogle Scholar
- 49.Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P (2018) Mu-opioid anatagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. Cochrane Database of Systematic Reviews Issue 6. Art. No.: CD006332Google Scholar
- 52.Dupoiron D, Stachowiak A, Loewenstein O, Ellery A, Kremers W, Bosse B, Hopp M (2017) A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR. Eur J Pain 21:1528–1537CrossRefGoogle Scholar
- 56.Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, de Conno F, Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M, Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D, Zeppetella G (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13:e58–e68CrossRefGoogle Scholar
- 57.National Comprehensive Cancer Network (2018) Adult cancer pain version 1.2018. National Comprehensive Cancer Network, Plymouth MeetingGoogle Scholar